The North America Hydrophobic Interaction Chromatography (HIC) market is poised for substantial growth between 2020 and 2035. With advancements in biopharmaceutical research and an increasing focus on monoclonal antibody production, the market’s size is projected to rise from USD 195 million in 2025 to USD 390 million by 2035 at a CAGR of 7.1% from 2024 to 2035. Market players such as GE Healthcare and Bio-Rad have been instrumental in driving technological innovation and expanding application scope, making the North America HIC market a key segment within the chromatography landscape.
The economic impact of tariffs on "North America Hydrophobic Interaction Chromatography Market".
Market Growth Drivers
Expanding Biopharmaceutical Sector: The rapid expansion of the biopharmaceutical sector is accelerating the demand for advanced purification techniques such as hydrophobic interaction chromatography. Companies like Thermo Fisher Scientific have reported an uptick in usage of HIC for protein and monoclonal antibody purification, helping to achieve higher yields and purity standards. The rise in therapeutic applications and biologics approvals has necessitated the use of robust chromatography solutions, thereby contributing directly to market growth.
Technological Advancements in Chromatography Solutions: Leading industry players, including GE Healthcare, are investing heavily in R&D to develop next-generation HIC resins and columns. Recent product launches feature improved selectivity, scalability, and automation, making HIC processes more efficient and cost-effective. These innovations are enabling pharmaceutical companies to streamline downstream processing, resulting in higher productivity and a shorter time-to-market for new drugs.
Market Trends
Integration of Automation and Digitalization: The incorporation of automation and digital monitoring in chromatography workflows is a notable trend. Companies such as Sartorius AG are introducing automated HIC solutions equipped with real-time analytics and AI-driven process controls, enhancing reproducibility and operational efficiency in bioprocessing labs.
Strong Adoption of Single-use Technologies: The shift towards single-use technologies in the biomanufacturing industry is significantly influencing the North America HIC market. New product launches from Pall Corporation and Cytiva have introduced disposable chromatography columns and systems, promoting rapid changeovers, minimizing cross-contamination, and driving cost efficiencies across manufacturing facilities.
Market Opportunities
Rising Biosimilar Production: The increasing focus on biosimilar development in North America presents a significant growth opportunity for HIC market players. Companies like Lonza are investing in HIC-based purification solutions to maintain product integrity and regulatory compliance in biosimilar manufacturing.
Expanding Academic and Research Collaborations: Growing collaborations between pharmaceutical companies and academic institutions are spurring innovation in protein purification techniques, including HIC. Initiatives led by institutions like MIT in partnership with leading biotech firms are expected to broaden the accessible expertise and accelerate scientific breakthroughs.
North America Hydrophobic Interaction Chromatography Market Revenue (USD Million), 2020-2035
The revenue trend for the North America HIC market indicates robust and consistent growth from USD 110 million in 2020 to an estimated USD 390 million by 2035. The market experiences a noticeable jump from 2024 onwards, driven by biopharmaceutical expansion and continuous technological advancements. The chart highlights a steady year-on-year increase, reflecting the sustained adoption of HIC in research and production environments across North America. Strategic investments by major industry players and the growing pipeline for biologics are expected to further boost revenue growth through the forecast period.
North America Hydrophobic Interaction Chromatography Market Share by Region (%), 2025
In 2025, the United States dominates the North America HIC market, accounting for 76% of the total share, primarily due to its advanced biopharma infrastructure and significant R&D investments. Canada holds 13%, supported by rapid technology adoption and government initiatives promoting pharmaceutical innovation. Mexico represents 7%, while emerging markets like Puerto Rico and Rest of North America contribute 2% each, reflecting their growing involvement in biosimilar and contract manufacturing activities. This regional distribution underscores the central role of the US in driving overall market growth.
Recent Market Developments
In February 2024, GE Healthcare announced the launch of its new HiTrap Capto Phenyl chromatography column specifically for hydrophobic protein purification. The product features enhanced selectivity and shorter processing times, targeting high-throughput biomanufacturing and enabling efficient purification of viral vectors and monoclonal antibodies.
In April 2024, Thermo Fisher Scientific partnered with a leading North American biopharma company to integrate digitalized automation into HIC workflows. This collaboration has improved throughput, reduced human error, and augmented process consistency across multi-site manufacturing networks, reinforcing Thermo Fisher's leadership in smart chromatography platforms.
In May 2024, Cytiva unveiled a strategic investment of USD 30 million in its Vancouver, Canada facility to expand HIC resin production capabilities. The expansion aims to meet surging demand from the North American bioprocessing sector and underlines Cytiva's commitment to technological innovation in chromatography consumables.
Press Releases